NM_001378183.1:c.5030-15G>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_001378183.1(PIEZO2):c.5030-15G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000174 in 1,533,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00091 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000093 ( 0 hom. )
Consequence
PIEZO2
NM_001378183.1 intron
NM_001378183.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.07
Publications
0 publications found
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
- Gordon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- arthrogryposis, distal, with impaired proprioception and touchInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
- arthrogryposis- oculomotor limitation-electroretinal anomalies syndromeInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- connective tissue disorderInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- Marden-Walker syndromeInheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 18-10718274-C-A is Benign according to our data. Variant chr18-10718274-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261513.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000913 (139/152246) while in subpopulation AFR AF = 0.0033 (137/41540). AF 95% confidence interval is 0.00285. There are 0 homozygotes in GnomAd4. There are 66 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PIEZO2 | NM_001378183.1 | c.5030-15G>T | intron_variant | Intron 36 of 55 | ENST00000674853.1 | NP_001365112.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PIEZO2 | ENST00000674853.1 | c.5030-15G>T | intron_variant | Intron 36 of 55 | NM_001378183.1 | ENSP00000501957.1 |
Frequencies
GnomAD3 genomes AF: 0.000914 AC: 139AN: 152128Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
139
AN:
152128
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000148 AC: 21AN: 141648 AF XY: 0.000119 show subpopulations
GnomAD2 exomes
AF:
AC:
21
AN:
141648
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000927 AC: 128AN: 1380848Hom.: 0 Cov.: 29 AF XY: 0.0000792 AC XY: 54AN XY: 681598 show subpopulations
GnomAD4 exome
AF:
AC:
128
AN:
1380848
Hom.:
Cov.:
29
AF XY:
AC XY:
54
AN XY:
681598
show subpopulations
African (AFR)
AF:
AC:
112
AN:
31502
American (AMR)
AF:
AC:
4
AN:
35668
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25156
East Asian (EAS)
AF:
AC:
0
AN:
35712
South Asian (SAS)
AF:
AC:
0
AN:
79110
European-Finnish (FIN)
AF:
AC:
0
AN:
35000
Middle Eastern (MID)
AF:
AC:
1
AN:
5686
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1075244
Other (OTH)
AF:
AC:
10
AN:
57770
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000913 AC: 139AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.000887 AC XY: 66AN XY: 74422 show subpopulations
GnomAD4 genome
AF:
AC:
139
AN:
152246
Hom.:
Cov.:
33
AF XY:
AC XY:
66
AN XY:
74422
show subpopulations
African (AFR)
AF:
AC:
137
AN:
41540
American (AMR)
AF:
AC:
1
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5192
South Asian (SAS)
AF:
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68028
Other (OTH)
AF:
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Dec 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.